Rose is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an editor.
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
New Clinical Guidelines Recommend Finerenone for CKD Associated With T2D
November 21st 2022Updated Kidney Disease: Improving Global Outcomes guidelines and a consensus report with the American Diabetes Association support the use of finerenone in certain patients who have chronic kidney disease (CKD) that may be linked to type 2 diabetes (T2D).
Read More
Some Patients With CAD Experience Sustained Remission After Sutimlimab Discontinuation
November 18th 2022A research letter published in Blood Advances details the first clinical evidence of sustained hematologic remission for cold agglutinin disease (CAD) after sutimlimab treatment discontinuation.
Read More
Study Highlights Value of PROs in Children With Sickle Cell Disease During Acute Pain Episodes
November 14th 2022Sufficiently powered studies are necessary to investigate associations between clinical measures and patient-reported outcomes (PROs) in children with sickle cell disease experiencing acute pain episodes, according to a recent study.
Read More
Report Suggests Best Practices for Care of Pediatric Sickle Cell Disease
November 12th 2022A panel of specialists proposed 26 essential elements for comprehensive pediatric sickle cell disease care, laying groundwork for standardized guidelines and the establishment of accredited care centers in the future.
Read More
NSAIDs May Be Safe for Use in Hemophilia, but More Research Is Needed
November 11th 2022The hesitation to prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) to patients with hemophilia is not supported by current research, based on a recently published review, but the available studies had significant limitations.
Read More
Need for More Research Into Chronic GVHD After Allogeneic HSCT Highlighted in New Review
November 9th 2022Although the understanding of chronic graft-versus-host disease (GVHD) has improved in recent years, more work is needed to facilitate personalized treatments for patients after hematopoietic stem cell transplantation (HSCT).
Read More
Cost-Savings Model Estimates Reduced Economic Burden With Gene Therapy for Hemophilia A
November 6th 2022Gene therapy is a novel approach to hemophilia A treatment that carries a substantial cost up front but may lead to cost savings compared with current prophylaxis agents in the long run.
Read More
Non–Driver Gene Mutations May Hold Predictive Value in ET and PV
November 1st 2022A recent study supports the notion that non–driver mutations in essential thrombocythemia (ET) and polycythemia vera (PV) have predictive value and found that a proposed international prognostication model may be useful for Japanese patients.
Read More
Stem Cells Highlighted as Potential Therapeutic Option in Huntington Disease
October 15th 2022Although no pharmacological treatment offers long-term efficacy or extends survival with Huntington disease at this point, research suggests that stem-cell therapy holds promise in this and other neurodegenerative diseases.
Read More
Review Underscores Potential and Obstacles of Universal CAR T-Cell Therapy
October 15th 2022Despite the obstacles and risks, the review authors conclude that universal chimeric antigen receptor (CAR) T-cell therapy has the potential to play a key role and mitigate some of the limitations associated with autologous CAR T-cell therapy in cancer treatment.
Read More